In this series of videos, International Chair of Life Sciences Cheryl Reicin provides valuable insights on a number of trends she is seeing in Big Pharma dealmaking and M&A. She discusses 2025 deal trends, M&A drivers, patent cliff impacts, and the hottest emerging sectors.
Drivers of Big Pharma M&A
Big Pharma Patent Cliff Impacts to M&A
What are the Hottest Sectors in the Life Science Industry?
Central Nervous System (CNS) Investment Opportunities
How Do You See Big Pharmas in AI?
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
